Morecroft Charles, Cantrill Judy, Tully Mary P
School of Pharmacy and Pharmaceutical Sciences, The University of Manchester, Manchester, UK.
Res Social Adm Pharm. 2006 Jun;2(2):186-211. doi: 10.1016/j.sapharm.2006.02.006.
The existing appropriateness measures for prescribing used in the United States and the United Kingdom use clinical attributes. Treatment and care from a patient's perspective need to be evaluated in terms of whether they are more likely to lead to an outcome of a life worth living, in social, psychological, and physical terms. However, it is unclear whether patients specifically evaluate their prescribed medication and treatment. If so, do they use only clinical attributes or a combination of clinical and nonclinical attributes?
The aim of this study was to explore if patients evaluated their hypertension management, and if they did, investigate what attributes were involved in the evaluation.
Semistructured interviews, which focused on personal experiences of hypertension and its management were undertaken with patients (n=28). The aim of the interviews was to obtain, in a narrative format, the experiences, beliefs, and information that patients considered important when discussing the management of hypertension. Data analysis used a constant comparative method.
All patients considered their hypertension management regimen appropriate, but were able to mention only 2 categories of attributes to justify their decision (the relationship with their General Practitioner and lowering of their blood pressure). Further series attributes were mentioned by the patient during the course of their interview; these attributes were considered to be involved in their evaluation. These implicit attributes were categorized as anxieties and concerns regarding treatment and diagnosis, explanation of the consequences of treatment, choice of antihypertensives, and the side effects experienced.
Patient's evaluation of appropriateness was constructed from both explicit and implicit attributes. Implicit attributes, those not consciously known to the patient still, could be involved in the process of evaluating hypertension, its treatment, and care. Although the nonmedical attributes that are considered by patients can be categorized, it has to be remembered that it is the inherent meaning held by each individual patient involved when an evaluation is made.
美国和英国现有的处方适宜性衡量标准采用临床属性。从患者的角度来看,治疗和护理需要根据其在社会、心理和生理方面是否更有可能带来值得过的生活的结果来进行评估。然而,尚不清楚患者是否会具体评估他们所开的药物和治疗。如果是这样,他们是仅使用临床属性还是临床和非临床属性的组合呢?
本研究的目的是探讨患者是否评估了他们的高血压管理情况,如果评估了,调查评估中涉及哪些属性。
对患者(n = 28)进行了半结构化访谈,重点是高血压及其管理的个人经历。访谈的目的是以叙述形式获取患者在讨论高血压管理时认为重要的经历、信念和信息。数据分析采用持续比较法。
所有患者都认为他们的高血压管理方案是合适的,但只能提及两类属性来证明他们的决定(与全科医生的关系以及血压降低)。在访谈过程中患者提到了更多系列的属性;这些属性被认为参与了他们的评估。这些隐性属性被归类为对治疗和诊断的焦虑和担忧、治疗后果的解释、抗高血压药物的选择以及所经历的副作用。
患者对适宜性的评估是由显性和隐性属性构成的。隐性属性,即患者仍未有意识知晓的属性,可能参与了高血压及其治疗和护理的评估过程。虽然患者考虑的非医学属性可以分类,但必须记住,评估时涉及的是每个个体患者所具有的内在意义。